Kira Glover-Cutter

3.5k total citations · 1 hit paper
20 papers, 2.6k citations indexed

About

Kira Glover-Cutter is a scholar working on Molecular Biology, Aging and Plant Science. According to data from OpenAlex, Kira Glover-Cutter has authored 20 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Aging and 3 papers in Plant Science. Recurrent topics in Kira Glover-Cutter's work include RNA Research and Splicing (7 papers), RNA modifications and cancer (5 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Kira Glover-Cutter is often cited by papers focused on RNA Research and Splicing (7 papers), RNA modifications and cancer (5 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Kira Glover-Cutter collaborates with scholars based in United States, Japan and Argentina. Kira Glover-Cutter's co-authors include David L. Bentley, T. Keith Blackwell, Soo‐Jin Kim, Sri Devi Narasimhan, Stacey Robida-Stubbs, Benjamin Erickson, Robert P. Fisher, Stéphane Larochelle, Kevan M. Shokat and Joaquı́n M. Espinosa and has published in prestigious journals such as Cell, Molecular Cell and Molecular and Cellular Biology.

In The Last Decade

Kira Glover-Cutter

20 papers receiving 2.6k citations

Hit Papers

TOR Signaling and Rapamycin Influence Longevity by Regula... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers

Kira Glover-Cutter
Comparison fields: 5 of 115
  • Molecular Biology 1.9k
  • Aging 594
  • Oncology 250
  • Endocrine and Autonomic Systems 247
  • Genetics 241
Replace Stefan Taubert with:
Stefan Taubert Canada
Paulien E. Polderman Netherlands
Edward Owusu-Ansah United States
Amy K. Walker United States
Barbara Conradt Germany
Ingrid Saarloos Netherlands
Swathi Arur United States
Mario G. Mirisola Italy
Scott Ogg United States
Christi A. Walter United States
Stefan Taubert Canada View profile →
Citations per field, relative to Kira Glover-Cutter
Kira Glover-Cutter · 1×
Citations per year, relative to Kira Glover-Cutter
Kira Glover-Cutter · 1×

Countries citing papers authored by Kira Glover-Cutter

Since Specialization
Citations

This map shows the geographic impact of Kira Glover-Cutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kira Glover-Cutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kira Glover-Cutter more than expected).

Fields of papers citing papers by Kira Glover-Cutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kira Glover-Cutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kira Glover-Cutter. The network helps show where Kira Glover-Cutter may publish in the future.

Co-authorship network of co-authors of Kira Glover-Cutter

This figure shows the co-authorship network connecting the top 25 collaborators of Kira Glover-Cutter. A scholar is included among the top collaborators of Kira Glover-Cutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kira Glover-Cutter. Kira Glover-Cutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 13
3 14
4 145
5 5
6 13
7 134
8
TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO breakdown →
504
9 300
10 28
11 140
12 165
13 9
14 114
15 1
16 239
17 268
18 155
19 268
20
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026